Romuald Tagne-Fotso,Margaux Riou,Abdessattar Saoudi,Abdelkrim Zeghnoun,Hanne Frederiksen,Tamar Berman,Parisa Montazeri,Anna-Maria Andersson,Laura Rodriguez-Martin,Agneta Akesson,Marika Berglund,Pierre Biot,Argelia Castaño,Marie-Aline Charles,Emmanuelle Cocco,Elly Den Hond,Marie-Christine Dewolf,Marta Esteban-Lopez,Liese Gilles,Eva Govarts,Cedric Guignard,Arno C Gutleb,Christina Hartmann,Tina Kold Jensen,Gudrun Koppen,Tina Kosjek,Nathalie Lambrechts,Rosemary McEachan,Amrit K Sakhi,Janja Snoj Tratnik,Maria Uhl,Jose Urquiza,Marina Vafeiadi,An Van Nieuwenhuyse,Martine Vrijheid,Till Weber,Cécile Zaros,Elena Tarroja-Aulina,Lisbeth E Knudsen,Adrian Covaci,Robert Barouki,Marike Kolossa-Gehring,Greet Schoeters,Sebastien Denys,Clemence Fillol,Loïc Rambaud

Abstract:Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies.

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A

Biomonitoring of occupational exposure to bisphenol A, bisphenol S and bisphenol F: A systematic review

Human-Biomonitoring derived exposure and Daily Intakes of Bisphenol A and their associations with neurodevelopmental outcomes among children of the Polish Mother and Child Cohort Study

The EuroMix human biomonitoring study: Source-to-dose modeling of cumulative and aggregate exposure for the bisphenols BPA, BPS, and BPF and comparison with measured urinary levels

Biomarkers of exposure to environmental contaminants in French pregnant women from the Elfe cohort in 2011

Human health risks related to the consumption of foodstuffs of animal origin contaminated by bisphenol A

Methodological approaches for the assessment of bisphenol A exposure

Biomonitoring of occupational exposure to phthalates: A systematic review

Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014-2016: Results from the Esteban study

Worldwide Human Daily Intakes of Bisphenol A (BPA) Estimated from Global Urinary Concentration Data (2000–2016) and Its Risk Analysis

Prenatal exposure to environmental bisphenols over time and their association with childhood asthma, allergic rhinitis and atopic dermatitis in the ECHO consortium

A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA)

Exposure to New Emerging Bisphenols Among Young Children in Switzerland

Effects and risk assessment of halogenated bisphenol A derivatives on human follicle stimulating hormone receptor: An interdisciplinary study

Including non-dietary sources into an exposure assessment of the European Food Safety Authority: The challenge of multi-sector chemicals such as Bisphenol A

Risk assessment of food contact materials

Exposure to Bisphenol A, Bisphenol F, and Bisphenol S in U.S. Adults and Children: the National Health and Nutrition Examination Survey 2013–2014

Urinary concentrations of phthalate/DINCH metabolites and body mass index among European children and adolescents in the HBM4EU Aligned Studies: A cross-sectional multi-country study

Comparative analysis of the bioaccumulation of bisphenol A in the blood serum and follicular fluid of women living in two areas with different environmental impacts